0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessCerebral amyloid angiopathy (CAA) is a small vessel disease characterized by β-amyloid deposition in cerebral vessel walls, leading to hemorrhagic and ischemic injuries. The Boston criteria 2.0 guide CAA diagnosis based on clinical and neuroimaging findings. Although imaging-based phenotypes have been well-defined, data on CSF biomarkers remain limited. Integrating CSF and imaging markers may improve understanding of CAA disease patterns. This study evaluates associations between CSF and neuroimaging biomarkers in CAA.
Raffaella Chieffo, Anna Del Poggio, Marco Vabanesi, Giacomo Giacalone, Miryam Cannizzaro, Beatrice Dell’Acqua, Marco Bacigaluppi, Mario Orrico, Andrea Falini, Nicoletta Anzalone, Massimo Filippi, Luisa Roveri (2025). Association of CSF β-Amyloid Biomarker and Imaging Markers in Cerebral Amyloid Angiopathy. , 1(3), DOI: https://doi.org/10.1212/wn9.0000000000000026.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2025
Authors
12
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1212/wn9.0000000000000026
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
